Objective: Examine whether the acute kidney injury (AKI) commonly observed among ultramarathon participants places the individual at risk for subsequent AKI of worse magnitude.
INTRODUCTION
Some degree of acute kidney injury (AKI) is relatively common in ultramarathon races, with documented incidence being 30% to 80%. 1, 2 In the majority of cases, such incidents go unnoticed, although hospitalization for AKI after an ultramarathon, albeit rare, does occur. 3, 4 Because of the nature of these athletic events, the most common etiology of AKI is rhabdomyolysis caused by muscle damage arising from the extraordinary levels of continuous exertion. In fact, in 161-km ultramarathons it is not uncommon to see serum creatine kinase (CK) concentrations well over 20 000 U/L, [5] [6] [7] which are at the level in which general guidelines not specific to ultramarathon runners would recommend treatment. 8, 9 The muscle breakdown products from rhabdomyolysis cause renal arteriolar vasoconstriction (20) . 10 Increased sympathetic tone, intravascular volume depletion, and the vasoconstrictive effect of nonsteroidal antiinflammatory drugs may also contribute to reduced renal perfusion and further increase the risk of AKI during an ultramarathon.
Given the high frequency of mild AKI during an ultramarathon, we asked whether such insults place a runner at risk for a subsequent similar event of the same, or perhaps higher, magnitude. Previous studies have suggested full recovery of resting renal chemistries overnight after a 56-km ultramarathon, 11 and after 40 to 80-km stages of a multistage ultramarathon with no apparent cumulative effect observed. 2 However, other studies have shown abnormalities of resting renal chemistries persisting the day after 100-km 12 and 56km 13 ultramarathons, and for several days after a 90-km ultramarathon. 14 It is possible that greater kidney insult could result from longer ultramarathons such as the race studied here. Furthermore, it is possible that resting renal chemistries may not fully reflect renal function under stressed conditions and in the presence of decreased intravascular volume.
In this study, we used data from multiple years of postrace blood analyses performed at the 161-km Western States Endurance Run (WSER) to track postrace serum creatinine concentrations in runners who met the criteria for AKI at the completion of one race. Our premise was that those with AKI at one race would have greater impairment in renal function after a subsequent race if such injuries are cumulative and without complete recovery of normal renal function during stress. Additionally, we examine the overall incidence of AKI using this large data set to expand on our previous work. 1 the 2013 event resulting in exclusion of this year from the study. The WSER is a 161-km point-to-point foot race which takes place during the last weekend in June. The course is almost entirely on single track mountain trails with 5500 m of cumulative climb and 7000 m of cumulative descent, and a 30-hour time limit for completion. Additional details of the race are provided elsewhere. [15] [16] [17] Ambient temperature data from weather stations near the course were used to determine the maximum temperature during each race. Institutional review board approval was obtained from the VA Northern California Health Care System with a waiver of consent.
All runners underwent prerace body weight measurement during registration in the morning of the day before the race started. Postrace body weight was measured immediately on completion of the race. All measurements were made with calibrated battery-operated digital scales (model 349KLX; Health o meter, Boca Raton, FL) placed on solid level surfaces. Each measurement was made with the runner clothed in running wear and shoes, and care was taken to assure that other items, such as jackets, waist packs, and hydration vests, were removed and nothing was in the runner's hands.
Within a few minutes after finishing the race, those runners who were willing to provide a blood sample had blood drawn while seated into heparinized tubes through an antecubital vein. A clinical laboratory performed analyses for serum creatinine, CK, and urea nitrogen.
On-line prerace and postrace questionnaires were used to gather information about running background and recent training of race participants in 2011 and 2014, respectively. Regarding information about years of regular running and years of running ultramarathons, information provided 1 year was used to generate missing data for other years when possible.
This study used the RIFLE (risk, injury, failure, loss, and endstage kidney disease) criteria for AKI. 18 Measured postrace serum creatinine at least 1.5 and 2.0 times baseline creatinine defined the risk and injury criteria, respectively. Because blood was not taken before the run, we estimated prerace serum creatinine concentration. An expected glomerular filtration rate (GFR) of 100 mL/min was used when age was #40 years, and 140 minus age was used for those .40 years of age. 19 The prerace expected GFR was then used in the "modification of diet in renal disease" equation 20 to backcalculate expected prerace serum creatinine concentration. Rearrangement of the same equation allowed calculation of postrace estimated GFR. Then, from these calculated GFR values, the prerace to postrace difference in GFR (DGFR) was determined.
Analyses were performed on the full group of runners with postrace blood results and the subset with postrace blood results from multiple races. Continuous data underwent normality testing with the D'Agostino-Pearson test. Characteristics of those meeting the criterion for injury, those meeting the criterion for risk, and those not meeting these criteria were compared with the Kruskal-Wallis test followed by Dunn multiple comparison test when an overall significant effect was identified because all of these variables had skewed data. Comparison of paired data was made with the paired t test or Wilcoxon matched-pairs signed-rank test depending on whether or not the data passed normality testing. Two-way (group · race number) were used to compare the subgroup of runners with data for 2 races who met the AKI risk or injury criterion both races with those who only met the criteria the first race. Categorical data were analyzed with the Chi-square or Fisher exact test. Correlations were performed with Pearson or Spearman correlation analyses depending on whether 
ETHICAL CONSIDERATIONS
This work was based on data collected during research approved by our institutional review board. No consenting specifically for the present analyses was required.
RESULTS
Among all 3 races, postrace blood was obtained for 627 (accounted for by 585 different runners) of the 922 race finishes. The risk criterion was met by 227 (36.2%) among which 31 (4.9%) also met the injury criterion. Selected characteristics of those meeting the injury criterion, those meeting the risk criterion, and those not meeting either criterion are shown in Table 1 . Those meeting the injury criterion lost more weight during the race and were faster than the others, and those meeting the risk criterion lost more weight than those not meeting either criterion. As expected, postrace serum creatinine concentrations varied among groups, as did postrace serum urea nitrogen. But age, sex, postrace serum CK concentration, running experience, and recent training did not vary among groups. Postrace serum CK and creatinine concentrations were significantly correlated (Figure 1 ).
There were 38 finishers who had undergone postrace blood analyses after at least 2 races. For 4 runners having 3 races with postrace blood studies, the first race and the other race with the most comparable finish time were selected for comparison. Among these 38 runners, 16 (42.1%) met the risk criterion of which 2 (5.3%) also met the injury criterion in the first race, and 18 (47.4%) met the risk criterion of which 3 (7.9%) also met the injury criterion in the second race. These incidences for this subset of 38 runners meeting the risk or injury criteria were similar (P = 0.49 and 0.17) to the 36.2% meeting the criteria when considering the full group of 627 finishes.
Considering the 16 runners meeting the risk or injury criterion in the first race, mean (6SD) age at the time of the first race was 41 6 10 years, 75% were men, and the mean interval between the 2 races was 1.5 years. Of these 16 runners who met the risk or injury criterion in the first race, 12 (75%) met the risk criterion (including 3 who met the injury criterion) in the second race. This 75% incidence of meeting the risk or injury criterion was higher than the 36.2% meeting the criteria when considering the full group of 627 finishes (P = 0.0026) and the 42.1% meeting the criteria in the first race among the subset of 38 runners with postrace blood analyses after at least 2 races (P = 0.038).
Individual data from the 2 races for DGFR and postrace serum creatinine for the 16 runners meeting the risk or injury criterion in the first race are compared in Figure 2 . There were no statistical differences between races for either variable (P . 0.3). Furthermore, it is evident from these plots that most (56.2%) of the individuals showed a lower DGFR at the second race compared with the first, and that both runners meeting the injury criterion in the first race showed a lower DGFR and serum creatinine concentration at the second race. Correlation analyses revealed no association between races for DGFR (P = 0.16) but a strong direct association for postrace serum creatinine concentration (r = 0.72, P = 0.003).
Among the 16 race finishers meeting the AKI risk or injury criterion in the first race, the group who met either criterion in the second race were compared with those not meeting either criterion in the second race ( Table 2 ). There were no statistical group, race number or interaction effects for maximum race temperature, finish placing or time, percentage body weight change, and postrace serum CK concentration. As expected, there were significant race number effects for age and years of running experience, but no group or interaction effects. For serum urea nitrogen, the interaction effect was nearly significant (P = 0.06) but group and race number effects were not evident.
DISCUSSION
The unusual degree of stress of an ultramarathon, even on the body of a healthy individual, puts the participant at risk for harm to several organ systems. The renal system seems particularly vulnerable for injury in these events given the extent of muscle damage, 1,3,21 the prevalent use of nonsteroidal antiinflammatory drugs, 5, 22, 23 and the ravages of intravascular volume shifts resulting from sweating and frequent occurrences of gastrointestinal fluid losses and inadequate fluid replacement. Because elevated serum creatinine, and hence attenuated GFR, occurs at least transiently in a relatively high percentage of ultramarathon runners, it is valuable to know whether such an event puts these individuals at risk for a similar or worse event during subsequent exercise. This has practical importance in that a runner may wish to limit his or her ultraendurance sports participation if it is known that each insult causes successive and cumulative renal damage.
The primary purpose of this study was to determine whether runners who showed some renal dysfunction at the conclusion of an ultramarathon were more likely to have similar or worse dysfunction in a subsequent ultramarathon of similar stress. Although several studies have shown resting renal chemistries normalize after an ultramarathon, 2, 11, 14 it is possible that resting renal chemistries may not fully reflect kidney function under stress. We are unaware of any previous work that has examined renal function after an ultramarathon in athletes who had AKI after a previous ultramarathon of similar stress. We now show, in a relatively small group of runners taking part in a 161-km ultramarathon, evidence that those with renal dysfunction (as assessed by serum creatinine) after 1 ultramarathon are more likely than other runners to have dysfunction of a similar magnitude after a subsequent ultramarathon of comparable stress, but that there is no evidence of dysfunction of higher magnitude occurring in the subsequent race. This finding should be reassuring to athletes and clinicians caring for endurance athletes. The findings also provide further rationale for avoiding overzealous rehydration because of concern for the renal system, which can place athletes with mild hyponatremia at risk for becoming acutely symptomatic. [24] [25] [26] There are several likely reasons for our findings, the most obvious being that the postrace elevation in serum creatinine in the runners meeting the risk or injury criterion was due to transient changes in renal perfusion from intravascular volume depletion, and vasoconstrictive effects of increased sympathetic tone, and nonsteroidal antiinflammatory drugs (if used). It is also possible that some of the runners can be undergoing acute renal arteriolar vasoconstriction as a result of muscle breakdown products from rhabdomyolysis. 10 This seems to be supported by a direct relationship between postrace serum CK and creatinine concentrations as identified in our study and past work. 1 Because there is no intrinsic renal damage in this scenario, the creatinine change is reversible and would not be expected to reflect a permanent change in kidney function. The present work also reports on a large data set (n = 627) of 161-km ultramarathon finishes showing the AKI risk criterion was met in 36.2% of the finishes, among which 4.9% also met the injury criterion. This was comparable with our previous analysis reporting that 34% met either AKI criterion among a subset of 207 of these finishes. 1 A comparison of selected characteristics of those meeting the AKI criteria showed that these individuals finished faster, had greater body weight loss during the race and had higher postrace serum CK and urea nitrogen concentrations when compared with those not meeting the AKI criteria. However, among the subset of runners with data for multiple races, there were no statistical differences in finish time or place, weight change, and postrace serum CK and urea nitrogen concentrations between those meeting the AKI criteria both races and those only meeting the criteria the first race, probably owing to the small sample size.
We acknowledge some limitations to this study, the most significant being that prerace serum creatinine concentration was not measured, thus we were required to impute the values expected of normal individuals from the GFR formulae. 20 Given the healthy state required of these runners, it is highly likely that the majority had a normal serum creatinine at the start of each race as supported by previous evidence for normal resting renal chemistries in ultramarathon runners. 2, [11] [12] [13] [14] We recognize that because creatinine (but not GFR) is roughly proportional to muscle mass, 27 highly muscular individuals could have confounded the data in that an underestimation of prerace serum creatinine concentration could have resulted in an incorrect determination that a runner met the risk or injury criterion for AKI. In other words, if prerace creatinine was actually higher than estimated at the first race, then some runners might have been incorrectly included in the group meeting the risk or injury criterion after that race. This is not likely to have been a common issue because the typical ultramarathon runner in this event is not overly muscular. 28, 29 Furthermore, we interpret the lack of any apparent change in postrace serum creatinine concentrations between the first and second races, which seemed to be of similar stress given statistically similar maximum ambient temperatures and race finish times, as important support for our conclusion that runners had full recovery from AKI of the first race. Of course, another limitation is the small sample size for the multiple year comparison component of this study and our lack of knowledge about the use of nonsteroidal antiinflammatory drugs by each specific runner. We also have no knowledge of the extent of previous AKI or intervening episodes of AKI that might have occurred between the first and second races examined in this study.
CONCLUSIONS
From this work, we conclude that it is common for 161-km ultramarathon runners to meet AKI criteria after a race. Those most likely to meet the criteria finish faster, have greater body weight loss during the race, and have higher postrace serum CK and urea nitrogen concentrations when compared with those not meeting the criteria. Most importantly though, there was no evidence that those with previous AKI had greater renal dysfunction with a subsequent exercise stimulus of similar magnitude. This should offer some reassurance to runners and their physicians that mild to moderate AKI in the setting of an ultramarathon is not cumulative and is likely associated in most cases with complete recovery not necessitating aggressive intervention. A prospective study with baseline prerace parameters would be the optimal approach for confirmation of our findings.
